Researchers at Australia's Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney have defined durations of impairment after THC dosing - but it's...
Jazz Pharmaceuticals subsidiary GW Pharmaceuticals has announced it has received approval in the UK for the use of Epidyolex to manage seizures associated with...